- The comprehensive evaluation of the immunometabolic phenotype of tumour microenvironment in breast cancer.
- Investigation of the underlying biology and immunomodulatory effects of anti-PD1 and metformin combination using targeted transcriptomics and multiplex immunohistochemistry in a breast tumour murine model.
Constantinos Savva graduated from the School of Medicine, University of Ioannina, Greece in 2010 with second upper honours. Completed successfully his MSc in Epidemiology offered by the London School of Hygiene & Tropical Medicine in 2011. From 2011 to 2015, he underwent Foundation and Core Medical training in Mersey and East of England deaneries, respectively. In 2015, he became a member of the Royal College of Physicians.
Subsequently, he was awarded an NIHR Academic Clinical Fellowship and a National Training Number in Medical Oncology at the University of Nottingham and Nottingham University Hospitals NHS Trust. In parallel, he completed the PGDip in Oncology offered by Newcastle University.
In 2018, he obtained a CRUK Clinical Research Fellowship in Cancer Immunology and Biology offered by the University of Southampton. During this periord, he also completed a PGCert in Clinical Bioinformatics offered by The University of Manchester.
Following the successfull completion of his PhD in breast cancer immunology in 2022, he was awarded an NIHR Clinical Lectureship in Medical Oncology.
- CRUK Clinical Research Training Fellowship (2018)
- Cancer Immunology Talent Fund (2021)